NCAM1 and neoplasm: NK cell inhibitory and activating receptors are not unique to NK cells as most are also expressed by CD8 T-cell subsets, with the exception of NKp46; furthermore, expression of CD56, CD16 and NKp46 (all routinely used as NK cell markers) is profoundly downregulated in tumor lesions [208,255,256,257,258].